BioXell

Business Data, Corporate Office and Headquarter Address

About

BioXell is Drug Discovery in Italy that focus on developer business. Founded in 2002. They cover business area such as developer, drug, urology and inflammatory disease.

Business Type

Drug Discovery

Country

Italy

Founded

2002
( 22 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

Via Olgettina, 58
20132 Milan
Italy

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerdrugurology and inflammatory disease

* We use standard office opening hours in near BioXell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

BioXell Frequently Asked Questions

What or who is BioXell?

BioXell is Drug Discovery business from Italy that founded in 2002 (22 years old in 2024), BioXell business is focusing on Developer.

Where is BioXell headquarter and corporate office address?

BioXell headquarter office and corporate office address is located in Via Olgettina, 58 20132 Milan Italy.

Where is BioXell country origins?

BioXell was founded in Italy.

What is Developer business focus on?

In 2024, BioXell is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with BioXell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.